Abstract
Aim of the study
To clarify the intestinal cancer risk in Crohn’s disease (CD).
Methods
20 clinical studies (1965–2008) with a total of 40,547 patients with Crohn’s disease-associated cancer (CDAC) were included in the meta-analysis (“inverse variance weighted” method).
Results
The incidence of CDAC in any CD patient was 0.8/1,000 person years duration (pyd) (CI, 0.6–1.0). The incidences of different carcinomas were: colorectal cancer 0.5/1,000 pyd (CI, 0.3–0.6), small bowel carcinoma 0.3/1,000 pyd (CI, 0.1–0.5), and cancers arising from CD-associated fistulae 0.2/1,000 pyd (CI, 0.0–0.4). Compared to the incidence in an age-matched standard population, the risk of colorectal cancer was increased by factor 2–3 and of small bowel cancer by factor 18.75, respectively. Mean patient age at diagnosis of CD-associated colorectal cancer was 51.5 years, thus 20 years earlier than in a standard population. The mean duration of CD until diagnosis of CDAC was 18.3 years. Duration of CD, age at diagnosis of CD, and anatomical area of CD involvement had no significant influence on cancer incidence.
Conclusions
CD is a risk factor for colorectal cancer, small bowel cancer, and fistula cancer; however, compared to ulcerative colitis, cancer risk is moderate.
Similar content being viewed by others
References
Friedrichs F, Brescianini S, Annese V, Latiano A, Berger K, Kugathasan S, Broeckel U, Nikolaus S, Daly MJ, Schreiber S, Rioux JD, Stoll M. Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet 2006:1–7.
Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004;36:476–480.
Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L, Giofre MR, Maggio A, Mattaliano A, Macaluso A, Cottone M. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn’s disease in Southern Italy. Am J Gastroenterol 2005;100:2730–2736
Aratari A, Papi C, Galletti B, Angelucci E, Viscido A, D’Ovidio V, Ciaco A, Abdullahi M, Caprilli R. Seasonal variations in onset of symptoms in Crohn’s disease. Dig Liver Dis 2005;38:319–323.
Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 2006;6:244–251.
Kersting S, Bruewer M, Laukoetter MG, Rijcken EM, Mennigen R, Buerger H, Senninger N, Krieglstein CF. Intestinal cancer in patients with Crohn’s disease. Int J Colorectal Dis 2007;22:411–417.
Edwards H. Crohn’s disease. J R Coll Surg Edinb 1964;64:115–127.
Johnson WR, McDermott FT, Hughes ES, Pihl EA, Milne BJ, Price AB. Carcinoma of the colon and rectum in inflammatory disease of the intestine. Surg Gynecol Obstet 1983;156:193–197.
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526–535.
Devroede G, Taylor WF. On calculating cancer risk and survival of ulcerative colitis patients with the life table method. Gastroenterology 1976;71:505–509.
Gilat T, Fireman Z, Grossman A, Hacohen D, Kadish U, Ron E, Rozen P, Lilos P. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology 1988;94:870–877.
Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800–806.
Ransohoff DF. Colon cancer in ulcerative colitis. Gastroenterology 1988;94:1089–1091.
Solomon MJ, Schnitzler M. Cancer and inflammatory bowel disease: bias, epidemiology, surveillance, and treatment. World J Surg 1998;22:352–358.
Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH, Jr., Greenstein AJ. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis–cancer interval. Gut 1991;32:167–169.
Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854–862.
Gillen CD, Andrews HA, Prior P, Allan RN. Crohn’s disease and colorectal cancer. Gut 1994;35:651–655.
Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590–1592.
Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH, Jr. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981;48:2742–2745.
Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology 1993;105:1716–1723.
Persson PG, Karlen P, Bernell O, Leijonmarck CE, Brostrom O, Ahlbom A, Hellers G. Crohn’s disease and cancer: a population-based cohort study. Gastroenterology 1994;107:1675–1679.
Dossett LA, White LM, Welch DC, Herline AJ, Muldoon RL, Schwartz DA, Wise PE. Small bowel adenocarcinoma complicating Crohn’s disease: case series and review of the literature. Am Surg 2007;73:1181–1187.
Ginzburg L, Schneider KM, Dreizin DH, Levinson C. Carcinoma of the jejunum occurring in a case of regional enteritis. Surgery 1956;39:347–351.
Oertli D, Rothenbuhler JM, Harder F (1993) Carcinoma of the small intestine in Crohn disease. Case report and review of the literature. Chirurg 64:346–348.
Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350–358.
Gollop JH, Phillips SF, Melton LJ, 3rd, Zinsmeister AR. Epidemiologic aspects of Crohn’s disease: a population based study in Olmsted County, Minnesota, 1943–1982. Gut 1988;29:49–56.
Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn’s disease. Gut 1980;21:1024–1029.
Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF. Crohn’s disease and cancer. N Engl J Med 1973;289:1099–1103.
Lipsey M, Wilson D. Practical meta-analysis. Thousand Oaks: Sage Publications, 2000.
Wilson D (2005) Meta-analysis stuff; macros for SPSS/win, Version 2005.05.23, George Mason University. Available at: http://mason.gmu.edu/~dwilsonb/ma.html; Accessed 10-01 2009.
Atwell JD, Duthie HL, Goligher JC. The outcome of Crohn’s disease. Br J Surg 1965;52:966–972.
Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994;35:950–954.
Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;343:1249–1252.
Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn’s disease. Gut 1994;35:347–352.
Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990;336:357–359.
Freeman HJ. Colorectal cancer complicating Crohn’s disease. Can J Gastroenterol 2001;15:231–236.
Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH, Jr. Patterns of neoplasia in Crohn’s disease and ulcerative colitis. Cancer 1980;46:403–407.
Korelitz BI. Carcinoma of the intestinal tract in Crohn’s disease: results of a survey conducted by the National Foundation for Ileitis and colitis. Am J Gastroenterol 1983;78:44–46.
Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn’s disease. Dis Colon Rectum 1998;41:992–996.
Kyle J, Ewen SW. Two types of colorectal carcinoma in Crohn’s disease. Ann R Coll Surg Engl 1992;74:387–390.
Lashner BA. Risk factors for small bowel cancer in Crohn’s disease. Dig Dis Sci 1992;37:1179–1184.
Lindgren A, Wallerstedt S, Olsson R. Prevalence of Crohn’s disease and simultaneous occurrence of extraintestinal complications and cancer. An epidemiologic study in adults. Scand J Gastroenterol 1996;31:74–78.
Otto HF, Bettmann I, von Weltzien JV. Crohn’s disease and intestinal cancer. A report of 5 cases and review of the literature. Z Gastroenterol 1980;18:583–593.
Petras RE, Mir-Madjlessi SH, Farmer RG. Crohn’s disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 1987;93:1307–1314.
Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH, Jr. Adenocarcinoma of the small intestine in Crohn’s disease. Surg Gynecol Obstet 1991;173:343–349.
Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum JR. Intestinal adenocarcinoma in Crohn’s disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol 1999;23:651–655.
Slater G, Greenstein A, Aufses AH, Jr. Anal carcinoma in patients with Crohn’s disease. Ann Surg 1984;199:348–350.
Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH, Jr., Greenstein AJ. Malignant colorectal strictures in Crohn’s disease. Am J Gastroenterol 1991;86:882–885.
Horner M, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse S, Feuer E, Huang L, Mariotto A, Miller B, Lewis D, Eisner M, Stinchcomb D, Edwards B (eds) SEER Cancer Statistics Review, 1975–2006. Bethesda: National Cancer Institute, 2009.
Office for National Statistics. Cancer statistics—registrations 1992. Series MB1 no. 25. London: The Stationery Office, 1992.
Rubio CA, Befritz R, Poppen B, Svenberg T, Slezak P. Crohn’s disease and adenocarcinoma of the intestinal tract. Report of four cases. Dis Colon Rectum 1991;34:174–180.
Simpson S, Traube J. The histologic appearance of dysplasia (precarcinomatous change) in Crohn’s disease of the small and large intestine. Gastroenterology 1981;81:492–450.
Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724–2729.
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 2006;23:1097–1104.
von Roon A, Reese G, Teare J, Constantinides V, Darzi A, Tekkis P. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum 2007;50:839–855.
Collier PE, Turowski P, Diamond DL. Small intestinal adenocarcinoma complicating regional enteritis. Cancer 1985;55:516–521.
Richards ME, Rickert RR, Nance FC. Crohn’s disease-associated carcinoma: a poorly recognized complication of inflammatory bowel disease. Ann Surg 1989;209:764–773.
Lee SD, Cohen RD. Endoscopy of the small bowel in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002;12:485–493.
Author information
Authors and Affiliations
Corresponding author
Additional information
M.G. Laukoetter and R. Mennigen contributed equally to this work.
M. Bruewer and C. Anthoni contributed equally to this work.
Rights and permissions
About this article
Cite this article
Laukoetter, M.G., Mennigen, R., Hannig, C.M. et al. Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis. J Gastrointest Surg 15, 576–583 (2011). https://doi.org/10.1007/s11605-010-1402-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-010-1402-9